0001213900-23-019936 | 10-K | XBRL Viewer

Goodwill

6. Goodwill

In connection with the ABC transaction, the Company has evaluated its Goodwill balances as of December 31, 2022 and has determined that there is an impairment of Goodwill related to its Health reporting unit. The impairment is primarily due to the ABC filing.

As a result of this impairment, the Company has recognized a non-cash charge of $2,921,958 in the year ended December 31, 2022 in the Consolidated Statements of Operations. The charge was recorded as part of Other Income in the Company’s Consolidated Statements of Operations and has no impact on its cash flow, liquidity, or compliance with debt covenants.

Additionally, the Company recorded Goodwill in connection with its acquisitions, the total Goodwill acquired in 2022 was $35,299,136.

The Company also updated the carrying value of the Goodwill in its Consolidated Balance Sheets to reflect the additional Goodwill and the impairment charge. The carrying value of Goodwill amounts $38,900,413, the changes in the carrying value of Goodwill for the period ended December 31, 2022 are as noted in the tables below:

	Carrying Value
Balance as of December 31, 2020	$	6,610,557
Goodwill acquired during the period		2,076,409
Balance as of December 31, 2021	$	8,686,966
Goodwill acquired during the period		35,299,136
Impairment during the year		(2,921,958	)
Reassignment of Goodwill to Assets held for sale		(2,163,731	)
Balance as of December 31, 2022	$	38,900,413

Intangibles

12 Months Ended

Dec. 31, 2022

Intangibles [Abstract]

Intangibles

7. Intangibles

The Company recorded amortization expenses of $3,214,814 and $1,845,193 as of December 31, 2022 and 2021, respectively.

	December 31, 2022
	Estimated Useful Life (Years)	Gross Carrying Amount		Additions			Accumulated Amortization			Net Carrying Amount
Patents	15 years	$	48,668	$	14,155		$	(10,116	)	$	52,707
Computer software	5 years		294,147		(46,319	)		(224,886	)		22,942
Operating licenses	Indefinite		8,375,514		423,490			-			8,799,004
Internally developed software	4-5 years		6,013,513		2,270,545			(6,378,911	)		1,905,147
Material contracts	Indefinite		-		62,550			-			62,550
Customer relationship	8-9 years		-		12,397,954			(594,301	)		11,803,653
Trademark	8 years		-		326,646			(3,403	)		323,243
		$	14,731,842	$	15,449,021		$	(7,211,617	)	$	22,969,246

	December 31, 2021
	Estimated Useful Life (Years)	Gross Carrying Amount		Additions		Accumulated Amortization			Net Carrying Amount
Patents	15 years	$	19,275	$	29,393	$	(6,367	)	$	42,301
Computer software	5 years		132,816		161,331		(219,388	)		74,759
Operating licenses	Indefinite		8,375,514		-		-			8,375,514
Internally developed software	4-5 years		2,146,501		3,867,012		(3,828,038	)		2,185,475
		$	10,674,106	$	4,057,736	$	(4,053,793	)	$	10,678,049

The estimated future amortization expense of definite life intangible assets as of December 31, 2022 is as follows:

	Amortization Expense
2023	$	2,494,148
2024		1,917,338
2025		1,867,861
2026		1,453,827
2027		1,453,109
Thereafter		4,921,409
Total	$	14,107,692

Accrued Liabilities

12 Months Ended

Dec. 31, 2022

Accrued Liabilities

8. Accrued Liabilities

Accrued liabilities consisted of the following at the dates indicated:

	December 31, 2022		December 31, 2021
Accrued bonus	$	1,500,717	$	7,260,456
Accrued lab fees		584,203		4,885,539
Accrued payroll		4,245,838		3,539,301
Medicare advance		-		975,415
FICA/Medicare liability		555,166		739,629
Accrued general expenses		11,436,462		3,497,418
Accrued subcontractors		8,101,150		9,564,833
Accrued fuel and maintenance		253,243		450,842
Accrued workers compensation and insurance liabilities		3,766,469		2,259,571
Other current liabilities		706,528		736,021
Accrued legal fees		344,417		1,143,629
Credit card payable		78,838		58,223
Total accrued liabilities	$	31,573,031	$	35,110,877

Line of Credit

12 Months Ended

Dec. 31, 2022

Line of Credit Facility [Abstract]

Line of Credit

9. Line of Credit

On December 17, 2021, Ambulnz-FMC North America, LLC (“FMC NA”), entered into a revolving loan and bridge credit and security agreement with a subsidiary of one of its members with a maximum revolving advance amount of $12,000,000. Each Revolving Advance shall bear interest at a per annum rate equal to the Wall Street Journal Prime Rate (7.75% as of March 10, 2023), as the same may change from time to time, plus one percent (1.00%), but in no event less than five percent (5.00%) per annum, calculated on the basis of a 360-day year for the actual number of days in the applicable period. The agreement is subject to certain financial covenants such as an unused fee, whereas the Company shall pay to the subsidiary of one of its members an unused fee in the amount of 0.5% of the average daily amount by which the Revolving Commitment Amount ($12,000,000) exceeds the principal balance of the aggregate outstanding advances. All accrued and unpaid interest and unused fee shall be due and payable on the first anniversary of the date of the agreement (“Revolving Credit Maturity Date”). This loan is secured by all assets of entities owned 100% by DocGo Inc. As of December 31, 2021, the outstanding balance of the line of credit was zero. On January 26, 2022, the company drew $1,000,000 to fund operations and meet short-term obligations. In December 2022, the Company did not renew the agreement, and repaid the outstanding balance.

On November 1, 2022, the Company entered into a revolving loan and security agreement with two banks, with one bank as the administrative agent (the “Lenders”), with a maximum revolving advance amount of $90,000,000. The revolving facility includes the ability for the Company to request an increase to the commitment by an additional up to $50,000,000, though no Lender (nor the Lenders collectively) are obligated to increase their respective commitments. Borrowings under the revolving facility bear interest at a per annum rate equal to, (i) at the Company’s option, the (x) the base rate or (y) the adjusted term SOFR rate, plus (ii) the applicable margin. The applicable margins are based on the Company’s consolidated net leverage ratio, adjusted on a quarterly basis. The Initial applicable margins are 1.25% for an adjusted term SOFR loan and 0.25% for a base rate loan and will be updated based on the consolidated net leverage ratio reported in the compliance certificate. The revolving facility matures on the five-year anniversary of the closing date, November 1, 2027. The revolving facility is secured by a first-priority lien on substantially all of the Company’s present and future personal assets and intangible assets. The revolving facility is subject to certain financial covenants such as a net leverage ratio and interest coverage ratio, as defined in the agreement. The Company has not made any draws under the facility and there is no amount outstanding. As of December 31, 2022, the outstanding balance of the line of credit is $0.

Notes Payable

12 Months Ended

Dec. 31, 2022

Notes Payable [Abstract]

Notes Payable

10. Notes Payable

The Company has various loans with finance companies with monthly installments aggregating $76,546, inclusive of interest ranging from 2.5% through 8%. The notes mature at various times through 2027 and are secured by transportation equipment.

The following table summarizes the Company’s notes payable:

	December 31, 2022		December 31, 2021
Equipment and financing loans payable, between 2.5% and 8% interest and maturing between January 2022 and October 2027	$	1,901,514	$	1,903,288
Loan received pursuant to the PPP Term Note		-		-
Total notes payable		1,901,514		1,903,288
Less: current portion of notes payable	$	664,913	$	600,449
Total non-current portion of notes payable	$	1,236,601	$	1,302,839

Interest expenses were $117,664 and $61,324 for the periods ended December 31, 2022 and 2021, respectively.

Future minimum annual maturities of notes payable as of December 31, 2022 are as follows:

	Notes Payable
2023	$	563,366
2024		443,416
2025		425,863
2026		345,557
Thereafter		123,312
Total maturities	$	1,901,514
Current portion of notes payable		(664,913	)
Non-current portion of notes payable	$	1,236,601

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI https://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Derivative Warrant Liabilities [Abstract]

Derivative Warrant Liabilities

12 Months Ended

Dec. 31, 2022

Derivative Warrant Liabilities

11. Derivative Warrant Liabilities

For the year ended December 31, 2021, the Company determined the fair value of its Public Warrants, which were previously traded in active markets, using quoted market prices for identical instruments. Accordingly, the Public Warrants were classified as Level 1 financial instruments. As of December 31, 2021, there were 3,833,333 Public Warrants outstanding at a fair value of $8.1 million. Because the transfer of Private Warrants to anyone outside of a small group of individuals constituting the sponsors of DocGo would result in the Private Warrants having substantially the same terms as the Public Warrants, management determined that the fair value of each Private Warrant was the same as that of a Public Warrant, with an insignificant adjustment for marketability restrictions. Accordingly, the Private Warrants were classified as Level 1 financial instruments. As of December 31, 2021, 2,533,333 Private Warrants remained outstanding at a fair value of $5.4 million. Due to fair value changes throughout the year ended December 31, 2021, we recorded a gain on remeasurement of warrant liabilities of $5.2 million.

As of December 31, 2022, the Company recorded a gain of approximately $1.1 million from the remeasurement of warrant liabilities. The warrants are marked-to-market in each reporting period, and this loss reflected the increase in DocGo’s stock price relative to the beginning of the period. On August 15, 2022, the Company announced the redemption of all of its outstanding warrants under the Warrant Agreement, dated as of October 14, 2020, by and between Motion Acquisition Corp. (“Motion”) and Continental Stock Transfer & Trust Company, as warrant agent, as part of the units sold in Motion’s initial public offering, on the redemption date of September 16, 2022 (the “Redemption Date”). Warrants surrendered for exercise on a cashless basis resulted in the issuance of 1,406,371 shares. A total of 68,514 warrants were not surrendered on the Redemption Date and were redeemed for $0.10 per warrant.

Business Segment Information

12 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

Business Segment Information

12. Business Segment Information

The Company conducts business as two operating segments, Transportation Services and Mobile Health services. In accordance with ASC 280, Segment Reporting, operating segments are components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker, who is the chief executive officer, in deciding how to allocate resources and assessing performance. The Company’s business operates in two operating segments because the Company’s entities have two main revenue streams, and the Company’s chief operating decision maker evaluates the Company’s financial information and resources and assesses the performance of these resources by revenue stream.

The accounting policies of the segments are the same as the accounting policies of the Company as a whole. The Company evaluates the performance of its Transportation services and Mobile Health services segments based primarily on results of operations.

Operating results for the business segments of the Company are as follows:

	Transportation Services			Mobile Health Services		Total
For the Year Ended December 31, 2022
Revenues	$	114,624,306		$	325,891,440	$	440,515,746
Income (loss) from operations		(45,676,221	)		67,507,849		21,831,628
Total assets		276,456,130			116,821,498		393,277,628
Depreciation and amortization expense		8,787,570			1,778,008		10,565,578
Stock compensation		2,013,643			6,040,928		8,054,571
Long-lived assets		32,302,611			50,825,223		83,127,834

For the Year Ended December 31, 2021
Revenues	$	84,268,817		$	234,449,763	$	318,718,580
Income (loss) from operations		(26,365,962	)		41,723,260		15,357,298
Total assets		229,206,964			80,395,688		309,602,652
Depreciation and amortization expense		5,508,679			2,002,900		7,511,579
Stock compensation		592,664			783,689		1,376,353
Long-lived assets		28,814,481			3,284,423		32,098,904

Long-lived assets include Property and equipment, Goodwill and Intangible assets.

Geographic Information

Revenues by geographic location included in Note 2.

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI https://asc.fasb.org/topic&trid=2134510

Stockholders' Equity Note [Abstract]

Equity

12 Months Ended

Dec. 31, 2022

Equity

13. Equity

Preferred Stock

In November 2021, the Company’s Series A preferred stock was cancelled and converted into the right to receive a portion of merger consideration issuable as common stock of DocGo, par value $0.0001 (“Common Stock”), pursuant to the terms and conditions set forth in the Merger Agreement. The Company’s Consolidated Statements of Changes in Stockholders’ Equity reflect the 2020 shares as if the merger occurred in 2020.

Prior to the reverse merger, on May 23, 2019, the Series A preferred stock was formed, and 40,000 shares were authorized. Each share of Series A preferred stock was convertible into Class A common stock at a conversion price of $3,000 per share, subject to adjustment as defined in the articles of incorporation.

Series A preferred stockholders had voting rights equivalent to the number of common stock shares issuable upon conversion. The Series A preferred stockholders were entitled to a non-cumulative dividends equal to 8% of the original issue price as defined in the agreement when declared by the board of directors.

The holders of the Series A preferred stock had preferential liquidation rights and rank senior to the holders of common stock. If a liquidation were to occur, the holders of the Series A preferred stock would have been paid an amount equal to $3,000 per share, subject to adjustment as defined in the articles of incorporation, plus all accrued and unpaid dividends thereon. After the payment of the Series A preferred stockholders, the common stockholders would have been paid out on a pro-rate basis.

Common Stock

On November 1, 2017, Ambulnz, Inc. converted its legal structure from a limited liability company to a corporation and converted its membership units into shares of common stock at a rate of 1,000 shares per membership unit. The total authorized number of shares of common stock converted was 100,000 shares, comprised of 35,597 shares of Class A common stock and 64,402 shares of Class B common stock.

Prior to the reverse merger, on May 23, 2019, the Ambulnz, Inc amended and restated its articles of incorporation and the total authorized common shares increased to 154,503 shares, comprised of 78,000 shares of Class A common stock and 76,503 shares of Class B common stock. The Class A common stockholders had voting rights equivalent to one vote per share of common stock and the Class B common stockholders have no voting rights. Dividends may be paid to the common stockholders out of funds legally available, when declared by the Board.

Share Repurchase Program

On May 24, 2022, the Company was authorized to purchase up to $40 million of the Company’s common stock under a share repurchase program (the “Program”). During the second and fourth quarter of 2022, the Company repurchased 536,839 shares of its common stock for $3,731,712. These shares were subsequently cancelled. There were no shares repurchased during the third quarter of 2022. The Program does not oblige the Company to acquire any specific number of shares and will expire on November 24, 2023. Under the Program, shares may be repurchased using a variety of methods, including privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as part of accelerated share repurchases, block trades and other methods. The timing, manner, price and amount of any common stock repurchases under the Program are determined by the Company in its discretion and depend on a variety of factors, including legal requirements, price and economic and market conditions.

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI https://asc.fasb.org/topic&trid=2208762

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008

Other Income and Expenses [Abstract]

Stock Based Compensation

12 Months Ended

Dec. 31, 2022

Stock Based Compensation [Abstract]

Stock Based Compensation

14. Stock Based Compensation

Stock Options

In 2021, the Company established the DocGo Inc. Equity incentive Plan (the “Plan”) replacing Ambulnz, Inc’s 2017 Equity Incentive Plan. The Plan reserved 16,607,894 shares of Class A common stock for issuance under the Plan. The Company’s stock options generally vest on various terms based on continuous services up to five years. The stock options are subject to time vesting requirements through 2026 and are nontransferable. Stock options granted have a maximum contractual term of 10 years. On December 31, 2022, approximately 2.6 million employee options had vested.

The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. Management took the company specific volatility and the average of several publicly traded companies that were representative of the Company’s size and industry in order to estimate its expected stock volatility. The expected term of the options represents the period of time the instruments are expected to be outstanding. The Company bases the risk-free interest rate on the rate payable on the U.S. Treasury securities corresponding to the expected term of the awards at the date of grant. Expected dividend yield is zero based on the fact that the Company has not historically paid and does not intend to pay a dividend in the foreseeable future.

Prior to the merger, the Company utilized contemporaneous valuations in determining the fair value of its shares at the date of option grants. Each valuation utilized both the discounted cash flow and guideline public company methodologies to estimate the fair value of its shares on a non-controlling and marketable basis. The March 11, 2021 valuation report relied solely on the fair value of the Company’s shares implied by the March 8, 2021 Merger Agreement with Motion Acquisition Corp.

For certain stock options issued prior to the Merger, a discount for lack of marketability was applied to the non-controlling and marketable fair value estimates determined above. The determination of an appropriate discount for lack of marketability was based on a review of discounts on the sale of restricted shares of publicly traded companies and put-based quantitative methods. Factors that influenced the size of the discount for lack of marketability include (a) the estimated time it would take for a Company stockholder to achieve marketability, and (b) the volatility of the Company’s business.

Subsequent to the Merger, the Company utilized publicly available pricing.

The following assumptions were used to compute the fair value of the sole stock option grant during the period ended December 31, 2022 and 2021:

	Years Ended December 31
	2022			2021
Risk-free interest rate		0.71% - 4.31	%		0.12% - 0.67	%
Expected term (in years)		6.25			1-5
Volatility		60% - 69	%		63% - 65	%
Dividend yield		0	%		0	%

The following table summarizes the Company’s stock option activity under the Plan for the period ended December 31, 2022:

	Options Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years		Aggregate Intrinsic Value

Balance as of December 31, 2020		4,635,898		$	1.84		7.28	$	8,129,671
Granted/ Vested during the year		5,495,095			2.88		9.80		-
Exercised during the year		(1,235,130	)		0.50		4.32		-
Cancelled during the year		(472,891	)		2.37		7.93		-
Balance as of December 31, 2021		8,422,972		$	6.21		8.77	$	24,706,020
Granted/ Vested during the year		5,443,368			7.04		-		-
Exercised during the year		(1,699,720	)		2.03		-		-
Cancelled during the year		(595,312	)		8.28		-		-
Balance as of December 31, 2022		11,571,308			7.11		9.05	$	39,389,063
Options vested and exercisable as of December 31, 2022		2,628,288		$	6.15		8.02	$	6,982,555

The aggregate intrinsic value in the above table is calculated as the difference between fair value of the Company’s common stock price and the exercise price of the stock options. The weighted average grant date fair value per share for stock option grants during the years ended December 31, 2022 and 2021 was $7.04 and $2.88, respectively. On December 31, 2022 and December 31, 2021, the total unrecognized compensation related to unvested stock option awards granted was $41,666,564 and $20,792,804, respectively, which the Company expects to recognize over a weighted-average period of approximately 2.16 years.

Restricted Stock Units

The fair value of restricted stock units (“RSUs”) is determined on the date of grant. The Company records compensation expenses in the Consolidated Statements of Operations and Comprehensive Income on a straight-line basis over the vesting period for RSUs. The vesting period for employees and members of the Board of Directors ranges from one to four years.

Activity under RSUs was as follows:

	RSUs			Weighted- Average Grant Date Fair Value Per RSU

Balance as of December 31, 2021		50,192		$	9.97
Granted		311,637			8.17
Vested during the year		(56,242	)		5.86
Balance as of December 31, 2022		305,587			8.35
Vested and unissued as of December 31, 2022		56,242			5.86
Non-vested as of December 31, 2022		305,587			8.35

The total grant-date fair value of RSUs granted during the period ended December 31, 2022 was $2,547,498.

In 2022, the company entered into agreements to issue $535,000 in aggregate RSUs in 2023. The number of shares to be issued in 2023 will be based on the stock prices at stated dates in these agreements.

For the year ended December 31, 2022, the Company recorded stock-based compensation expense related to RSUs of $870,579.

As of December 31, 2022, the Company had $2,177,713 in unrecognized compensation cost related to non-vested RSUs, which is expected to be recognized over a weighted-average period of approximately 1.7 years.

Leases

12 Months Ended

Dec. 31, 2022

Disclosure of Leases [Abstract]

Leases

15. Leases

Operating Leases

The Company is obligated to make rental payments under non-cancellable operating leases for office, dispatch station space, and transportation equipment, expiring at various dates through 2029. Under the terms of the leases, the Company is also obligated for its proportionate share of real estate taxes, insurance and maintenance costs of the property. The Company is required to hold certain funds in restricted cash and cash equivalents accounts under some of these agreements.

Certain leases for property and transportation equipment contain options to purchase, extend or terminate the lease. Determining the lease term and amount of lease payments to include in the calculation of the right-of-use (ROU) asset and lease obligations for leases containing options requires the use of judgment to determine whether the exercise of an option is reasonably certain and whether the optional period and payments should be included in the calculation of the associated ROU asset and lease obligation. In making the determination of such judgment, the Company considers all relevant economic factors that would require whether to exercise or not exercise the option.

The Company’s lease agreements generally do not provide an implicit borrowing rate. Therefore, the Company used a benchmark approach to derive an appropriate imputed discount rate. The Company benchmarked itself against other companies of similar credit ratings and comparable quality and derived imputed rates, which were used to discount its real estate lease liabilities. The Company used estimated borrowing rates of 6% on January 1, 2019, for all leases that commenced prior to that date, for office spaces and transportation equipment.

Lease Costs

The table below comprise lease expenses for the periods ended December 31, 2022 and 2021, respectively:

Components of total lease cost:	December 31, 2022		December 31, 2021
Operating lease expense	$	2,294,636	$	1,993,984
Short-term lease expense		1,201,622		1,012,260
Total lease cost	$	3,496,258	$	3,006,244

Lease Position as of December 31, 2022

Right-of-use lease assets and lease liabilities for the Company’s operating leases were recorded in the Consolidated Balance Sheets as follows:

	December 31, 2022		December 31, 2021
Assets
Lease right-of-use assets	$	9,074,277	$	4,195,682
Total lease assets	$	9,074,277	$	4,195,682

Liabilities
Current liabilities:
Lease liability – current portion	$	2,325,024	$	1,461,335
Noncurrent liabilities:
Lease liability, net of current portion		7,040,982		2,980,946
Total lease liability	$	9,366,006	$	4,442,281

Lease Terms and Discount Rate

Weighted average remaining lease term (in years) – operating leases			5.57
Weighted average discount rate – operating leases			6.00	%

Undiscounted Cash Flows

Future minimum lease payments under the operating leases as of December 31, 2022 are as follows:

	Operating Leases
2023	$	2,788,584
2024		2,346,789
2025		2,345,424
2026		1,716,501
2027 and thereafter		1,440,116
Total future minimum lease payments		10,637,414
Less effects of discounting	$	(1,271,408	)
Present value of future minimum lease payments	$	9,366,006

Operating lease expenses approximated $2,294,636 and $1,993,984 for the years ended December 31, 2022 and 2021, respectively.

For the year ended December 31, 2022, the Company made $2,294,636 of fixed cash payments related to operating leases and $2,985,568 related to finance leases.

Finance Leases

The Company leases vehicles under a non-cancelable finance lease agreements with a liability of $8,646,803 and $10,139,410 for the periods ended December 31, 2022 and 2021, respectively (accumulated depreciation of $7,906,966 and $7,095,242 as of December 31, 2022 and 2021, respectively).

Depreciation expenses for the vehicles under non-cancelable lease agreements amounted to $3,236,418 and $2,913,925 for the years ended December 31, 2022 and 2021, respectively.

Gain on Lease Remeasurement

In June 2022, the Company reassessed its finance lease estimates relating to vehicle mileage and residual value. As a result, the Company determined to purchase the vehicles at the end of the leases which resulted in a gain of $1.4 million recorded as gains from lease accounting on the Consolidated Statements of Operations and Comprehensive Income.

Lease Payments

The table below comprise lease payments for the periods ended December 31, 2022 and 2021, respectively:

Components of total lease payment:	December 31, 2022		December 31, 2021
Finance lease payment	$	2,985,568	$	2,741,784
Short-term lease payment		-		-
Total lease payments	$	2,985,568	$	2,741,784

Lease Position as of December 31, 2022

Right-of-use lease assets and lease liabilities for the Company’s finance leases were recorded in the Consolidated Balance Sheets as follows:

	December 31, 2022		December 31, 2021
Assets
Lease right-of-use assets	$	9,039,663	$	9,307,113
Total lease assets	$	9,039,663	$	9,307,113

Liabilities
Current liabilities:
Lease liability – current portion	$	2,732,639	$	3,271,990
Noncurrent liabilities:
Lease liability, net of current portion		5,914,164		6,867,420
Total lease liability	$	8,646,803	$	10,139,410

Lease Terms and Discount Rate

The table below presents certain information related to the weighted average remaining lease term and the weighted average discount rate for the Company’s finance leases as of December 31, 2022:

Weighted average remaining lease term (in years) – finance leases			4
Weighted average discount rate – finance leases			6.0	%

Undiscounted Cash Flows

Future minimum lease payments under the finance leases as of December 31, 2022 are as follows:

	Finance Leases
2023	$	3,156,298
2024		2,438,224
2025		2,159,661
2026		1,377,432
2027 and thereafter		468,651
Total future minimum lease payments		9,600,266
Less effects of discounting	$	(953,463	)
Present value of future minimum lease payments	$	8,646,803

Other Income (loss)

12 Months Ended

Dec. 31, 2022

Other Income (loss)

16. Other Income (Loss)

The Company recognized $950,264 and 4,437,887 of Other income for the years ended December 31, 2022 and December 31, 2021, respectively, as follows:

	Years Ended December 31
	2022			2021

Other income (expenses):
Interest income (expense), net		762,685			(763,030	)
Gain on remeasurement of warrant liabilities		1,127,388			5,199,496
Gain (loss) on initial equity method investment		8,919			(66,818	)
Gain on remeasurement of finance leases		1,388,273			-
Gain on bargain purchase		1,593,612			-
Gain from PPP loan forgiveness		-			142,667
Loss on disposal of fixed assets		(21,173	)		(34,342	)
Goodwill impairment		(2,921,958	)		-
Other expenses		(987,482	)		(40,086	)
Total other income		950,264			4,437,887

Related Party Transactions

12 Months Ended

Dec. 31, 2022

Related Party Transactions

17. Related Party Transactions

Historically, the Company has been involved in transactions with various related parties.

Ely D. Tendler Strategic & Legal Services PLLC provides legal services for the Company. Ely D. Tendler Strategic & Legal Services PLLC is owned by the General Counsel of the Company, and therefore is a related party. The Company made legal payments to Ely D. Tendler Strategic & Legal Services PLLC totaling $960,081 and $702,083 for the years ended December 31, 2022, and 2021, respectively.

PrideStaff provides subcontractor services for the Company. PrideStaff is owned by the operations manager of the Company and his spouse, and therefore, a related party. The Company made subcontractor payments to PrideStaff totaling $547,500 and $656,883 for the years ended December 31, 2022, and 2021, respectively.

Included in Accounts payable were $86,555 and $230,517 due to related parties as of December 31, 2022, and 2021, respectively.

Income Taxes

12 Months Ended

Dec. 31, 2022

Income Taxes [Abstract]

Income Taxes

18. Income Taxes

A reconciliation of the statutory U.S. federal income tax rate to the Company’s effective tax rate consist of the following:

	For the Years Ended December 31,
	2022			2021
Statutory federal income tax benefit		21.00	%		21.00	%
Permanent items		0.56	%		(2.71	)%
State taxes, net of federal tax benefit		7.77	%		5.99	%
Effects of Rates Different from Statutory		0.17	%		(0.06	)%
Rate Change		0.01	%		0.00	%
Other		(3.64	)%		(0.71	)%
Change in valuation allowance		(54.94	)%		(20.98	)%
Income tax (benefit)/provision		(29.07	)%		2.53	%

The components of income tax provision (benefit) are as follows:

	For the Years Ended December 31,
	2022			2021
Current:
Federal	$	1,493,772		$	295,956
State and local		502,872			319,741
Foreign		-			-
	$	1,996,644		$	615,697
Deferred:
Federal	$	(7,683,475	)	$	-
State and local		(2,649,791	)		-
Foreign		375,301			-
		(9,957,965	)		-
Total income tax (benefit) expense	$	(7,961,321	)	$	615,697

Deferred income taxes reflect the net tax effects of temporary differences between the carrying value of assets and liabilities for financial reporting purposes and amounts used for income tax purposes. The temporary differences that give rise to deferred tax assets and liabilities are as follows:

	For the Years Ended December 31,
	2022			2021
Deferred tax assets (liabilities):
Net operating loss carryforwards	$	11,523,632			17,153,341
Allowance for doubtful accounts		893,329			874,029
Amortization		(157,839	)		(582,284	)
Prepaid expenses		(994,644	)		(411,798	)
Property and equipment		(2,798,988	)		(2,245,003	)
Research and development expense		303,446			(580,497	)
Accrued bonus		(184,724	)		1,414,357
Stock compensation		2,780,019			883,317
Other		114,080			197,218
Net deferred tax assets		11,478,311			16,702,680
Valuation allowance		(1,520,345	)		(16,702,680	)
Deferred tax assets, net of allowance	$	9,957,966		$	-

The Company has determined, based upon available evidence, that it is more likely than not that all of the net deferred tax asset will not be realized and, accordingly, has provided a partial and a full valuation allowance against its net deferred tax asset as of December 31, 2022 and 2021, respectively. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, net operating loss carryback potential, and tax planning strategies in making these assessments.

As of December 31, 2022 and 2021, the Company had federal net operating loss carryforwards of approximately $35,289,184 and $53,573,046, respectively. As of December 31, 2022 and 2021, the Company had approximately $1,520,345 and $202,965 of foreign net operating loss carryforwards, respectively. As of December 31, 2022 and 2021, the Company had state net operating loss carryforward of approximately $2,592,560 and $67,229,895, respectively. The federal net operating loss carryforwards generated after December 31, 2017 of $35,289,184 carry forward infinitely. State and foreign net operating loss carryforwards generated in the tax years from 2017 to 2020 will begin to expire, if not utilized, by 2039. Utilization of the net operating loss carryforwards may be subject to an annual limitation according to Section 382 of the Internal Revenue Code of 1986 as amended, and similar provisions.

The difference between the statutory income taxes on the Company’s pre-tax loss and the Company’s effective income tax rate during the years ended December 31, 2022 and 2021 is primarily due to a recorded valuation allowance. The valuation allowance for deferred tax assets as of December 31, 2022 and 2021 was $1,520,345 and $16,702,680, respectively. The net change in the total valuation allowance for the years ended December 31, 2022, and 2021 was a decrease of $15,182,335 and $5,328,621, respectively.

In assessing the realizability of the deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future table income during the periods in which those temporary differences become deductible. Management considers the scheduled reversals of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment.

The Company recognizes interest accrued to unrecognized tax benefits and penalties as income tax expense. The Company accrued total penalties and interest of $0 during the years ended December 31, 2022 and 2021 and in total, as of both December 31, 2022 and 2021 has recognized penalties and interest of $0.

The Company files tax returns as prescribed by the tax laws of the jurisdictions in which they operate. In the normal course of business, the Company is subject to examination by federal and foreign jurisdictions where applicable based on the statute of limitations that apply in each jurisdiction. As of December 31, 2022, open years related to all jurisdictions are 2021, 2020, and 2019. The Company has no open tax audits with any taxing authority as of December 31, 2022.

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI https://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

401(K) Plan

12 Months Ended

Dec. 31, 2022

401(K) Plan [Abstract]

401(K) Plan

19. 401(K) Plan

The Company has established a 401(k) plan in January 2022 that qualifies as a deferred compensation arrangement under Section 401 of the Internal Revenue Code. All U.S. employees that complete two months of service with the Company are eligible to participate in the plan. The Company did not make any employer contributions to this plan as of December 31, 2022 except for one subsidiary. Exceptional matched the 401K plan contributions amounting to $226,260 for the year ended December 31, 2022.

The entire disclosure for retirement benefits.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section S99
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (o)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (p)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI https://asc.fasb.org/topic&trid=2235017

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (l)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Legal Proceedings

12 Months Ended

Dec. 31, 2022

Description of Organization and Business Operations [Abstract]

Legal Proceedings

20. Legal Proceedings

From time to time, the Company may be involved as a defendant in legal actions that arise in the normal course of its business. In the opinion of management, the Company has adequate legal defense on all legal actions, and the results of any such proceedings would not materially impact the Consolidated Financial Statements of the Company. The Company discloses and records loss contingencies in accordance with the loss contingencies accounting guidance. In accordance with such guidance, the Company establishes accruals for such matters when potential losses become probable and can be reasonably estimated. If the Company determines that a loss is reasonably possible and the loss or range of loss can be estimated, the Company discloses the possible loss in its Consolidated Financial Statements.

As of December 31, 2022 and December 31, 2021, the Company recorded a liability of $1,000,000, which represented an agreed-upon settlement of various class-based claims, both actual and potential, under California state law, as described in detail below.

Stephanie Zamora, Jascha Dlugatch, et al. v. Ambulnz Health, LLC, et al. was filed in the Los Angeles Superior Court on October 11, 2018, and the complaint alleged wage and hour violations pursuant to California’s Private Attorneys’ General Act of 2004 (“PAGA”). On February 24, 2020, this case was consolidated with Jascha Dlugatch, et. al. v. Ambulnz Health, LLC (the “Consolidated Compliant”), another lawsuit filed in the Los Angeles Superior Court. On May 6, 2021, the parties attended mediation and settled the claims pled in the Consolidated Complaint on a class-wide and PAGA basis in exchange for a proposed $1,000,000 payment by the defendant parties, inclusive of administrative costs and fees. On September 9, 2022, the Court preliminarily approved the proposed settlement. A final approval hearing is currently scheduled for April 28, 2023.

Risk and Uncertainties

12 Months Ended

Dec. 31, 2022

Risks and Uncertainties [Abstract]

Risk and Uncertainties

21. Risk and Uncertainties

COVID-19 Risks, Impacts and Uncertainties

The spread of COVID-19 and the related country-wide shutdowns and restrictions had a mixed impact on the Company’s business. In the ambulance transportation business, which predominantly comprises of non-emergency medical transportation, the Company saw a decline in volumes from historical and expected levels, as elective surgeries and other procedures were postponed. In some of the Company’s larger markets, such as New York and California, there were declines in trip volume. In addition, the Company experienced lost revenues associated with sporting, concerts and other events, as those events were cancelled or had a significantly restricted (or entirely eliminated) the number of permitted attendees. Ambulance transports and event-related revenues have both since recovered to pre-COVID levels or higher.

There are two areas where the Company has experienced positive business impacts from COVID-19. In April and May 2020, the Company participated in an emergency project with Federal Emergency Management Agency (“FEMA”) in the New York City area. This engagement resulted in incremental transportation revenue. In addition, in response to the need for widespread COVID-19 testing and available EMT and Paramedics, the Company formed a new subsidiary, Rapid Reliable Testing, LLC (“RRT”), with the goal to perform COVID-19 tests at nursing homes, municipal sites, businesses, schools and other venues. RRT is part of the Mobile Health segment. Since early 2020, RRT has grown significantly, and its services have expanded beyond COVID-19 testing to a wide variety of tests, vaccinations and other procedures. While COVID-19 testing activity continued to grow throughout 2021 and into early 2022, such activity has slowed considerably over the past several months, as the pandemic has waned, and COVID-19 testing accounted for a relatively small proportion of the Company’s overall revenues during the third and fourth quarters of 2022. DocGo anticipates that COVID-19 will continue to account for a shrinking proportion of the Company’s revenues in 2023 and beyond.

The Company’s current business plan assumes continued recovery of industry-wide transportation volumes to historical levels and beyond, plus an increased demand for mobile health services, a demand that was accelerated by the pandemic, but which is also being driven by longer-term secular factors, such as the increasing desire on the part of patients to receive treatments outside of traditional settings, such as doctor’s offices and hospitals. However, given the unpredictable, unprecedented, and fluid nature of the pandemic and its economic consequences, we are unable to predict the duration and extent to which the pandemic and its related positive and negative impacts will affect our business, financial condition, and results of operations in future periods. Likewise, we are unable to predict the emergence of future, unrelated pandemics, which would have some of the same impacts as those experienced with COVID-19.

Medicare Accelerated Payments

Medicare accelerated payments of approximately $2,397,024 were received by the Company in April 2020. Effective October 8, 2020, CMS is no longer accepting new applications for accelerated payments. There were no Medicare accelerated payments reflected within accrued liabilities in the Consolidated Balance Sheets as of December 31, 2022, compared to $975,415 as of December 31, 2021.

Subsequent Events

12 Months Ended

Dec. 31, 2022

Subsequent Events [Abstract]

Subsequent Events

22. Subsequent Events

Accounting Policies, by Policy (Policies)

12 Months Ended

Dec. 31, 2022

Basis of Presentation

Basis of Presentation

Principles of Consolidation

Principles of Consolidation

Foreign Currency

Foreign Currency

Use of Estimates

Use of Estimates

Concentration of Credit Risk and Off-Balance Sheet Risk

Concentration of Credit Risk and Off-Balance Sheet Risk

Major Customers

Major Customers

The Company had one customer that accounted for approximately 35% of sales and 45% of net accounts receivable, for the year ended December 31, 2022.

Major Vendor

Major Vendor

The Company had one vendor that accounted for approximately 11% of total cost for the years ended December 31, 2021.

Emerging Growth Company

Emerging Growth Company

Cash and Cash Equivalents

Cash and Cash Equivalents

Restricted Cash

Restricted Cash

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The accounting guidance classifies fair value measurements in one of the following three categories for disclosure purposes:

Level 1:

Quoted prices in active markets for identical assets or liabilities.

Level 2:

Inputs other than Level 1 prices for similar assets or liabilities that are directly or indirectly observable in the marketplace.

Level 3:

Accounts Receivable

Accounts Receivable

Property and Equipment

Property and Equipment

Asset Category		Estimated Useful Lives
Buildings		39 years
Office equipment and furniture		3 years
Vehicles		2-8 years
Medical equipment		5 years
Leasehold improvements		Shorter of useful life of asset or lease term

Expenditures for repairs and maintenance are charged to expense as incurred. Expenditures that improve an asset or extend its estimated useful life are capitalized.

Software Development Costs

Software Development Costs

Business Combinations

Business Combinations

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

Goodwill and Indefinite-Lived Intangible Assets

Goodwill and Indefinite-Lived Intangible Assets

Line of Credit

Line of Credit

The costs associated with the line of credit are deferred and recognized over the term of the Line of credit as interest expense.

Derivative Warrant Liabilities

Derivative Warrant Liabilities

Related Party Transactions

Related Party Transactions

Revenue Recognition

Revenue Recognition

On January 1, 2019, the Company adopted ASU 2014-09, Revenue from Contracts with Customers (“ASC 606”), as amended.

Nature of Our Services

Revenue is primarily derived from:

ii.	Mobile Health Services: These services include services performed at home and offices, COVID-19 testing, and event services which include on-site healthcare support at sporting events and concerts.

Disaggregation of revenue

In the following table, revenue is disaggregated by as follows:

	Years Ended December 31,
Revenue Breakdown	2022		2021
Primary Geographical Markets
United States	$	419,578,082	$	309,218,594
United Kingdom		20,937,664		9,499,986
Total revenue	$	440,515,746	$	318,718,580

Major Segments/Service Lines
Transportation Services	$	114,624,306	$	84,268,817
Mobile Health		325,891,440		234,449,763
Total revenue	$	440,515,746	$	318,718,580

Stock Based Compensation

Stock Based Compensation

Earnings per Share

Earnings per Share

The following table presents the calculation of basic and diluted net income per share to stockholders of DocGo Inc. and Subsidiaries:

	For the years ending December 31,
	2022		2021
Net income attributable to stockholders of DocGo Inc. and Subsidiaries:	$	34,584,498	$	23,743,758
Weighted-average shares - basic		101,228,369		80,293,959
Effect of dilutive options		1,747,462		14,569,654
Weighted-average shares - dilutive		102,975,831		94,863,613
Net income share - basic	$	0.34	$	0.30
Net income share - diluted	$	0.34	$	0.25
Anti-dilutive employee share-based awards excluded		9,000,750		-

Equity Method Investment

Equity Method Investment

Leases

Leases

Income Taxes

Income Taxes

Recently Issued Accounting Standards Not Yet Adopted

Recently Issued Accounting Standards Not Yet Adopted

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2022

Description of Organization and Business Operations [Abstract]

Schedule of depreciation and amortization using the straight-line method over the estimated useful lives of the respective assets

Asset Category		Estimated Useful Lives
Buildings		39 years
Office equipment and furniture		3 years
Vehicles		2-8 years
Medical equipment		5 years
Leasehold improvements		Shorter of useful life of asset or lease term

Schedule of revenue is disaggregated

	Years Ended December 31,
Revenue Breakdown	2022		2021
Primary Geographical Markets
United States	$	419,578,082	$	309,218,594
United Kingdom		20,937,664		9,499,986
Total revenue	$	440,515,746	$	318,718,580

Major Segments/Service Lines
Transportation Services	$	114,624,306	$	84,268,817
Mobile Health		325,891,440		234,449,763
Total revenue	$	440,515,746	$	318,718,580

Schedule of basic and diluted net income per share

	For the years ending December 31,
	2022		2021
Net income attributable to stockholders of DocGo Inc. and Subsidiaries:	$	34,584,498	$	23,743,758
Weighted-average shares - basic		101,228,369		80,293,959
Effect of dilutive options		1,747,462		14,569,654
Weighted-average shares - dilutive		102,975,831		94,863,613
Net income share - basic	$	0.34	$	0.30
Net income share - diluted	$	0.34	$	0.25
Anti-dilutive employee share-based awards excluded		9,000,750		-

Property and Equipment, net (Tables)

12 Months Ended

Dec. 31, 2022

Property, Plant and Equipment [Abstract]

Schedule of property and equipment, net

	December 31, 2022			December 31, 2021

Office equipment and furniture	$	2,686,065		$	1,977,808
Buildings		527,283			527,284
Land		37,800			37,800
Transportation equipment		20,773,862			13,772,251
Medical equipment		5,177,520			3,949,566
Leasehold improvements		579,658			616,446
		29,782,188			20,881,155
Less: Accumulated depreciation		(8,524,013	)		(8,147,266	)
Property and equipment, net	$	21,258,175		$	12,733,889

Acquisitions (Tables)

12 Months Ended

Dec. 31, 2022

Acquisition of Businesses and Asset Acquisitions [Abstract]

Schedule of preliminary allocation of the assets acquired and liabilities assumed

	Location Medical Services		Community Ambulance Service			Ryan Brothers		Exceptional Medical Transport		Government Medical Services		Total

Consideration:
Cash consideration	$	302,450	$	5,541,269		$	7,422,252	$	6,375,000	$	20,338,789	$	39,979,760
Deferred consideration		11,279,201		-			-		6,000,000		-		17,279,201
Amounts held under an escrow account		-		-			-		1,333,333		-		1,333,333
Contingent consideration		2,475,540		-			4,000,000		1,080,000		3,000,000		10,555,540
Total consideration		14,057,191		5,541,269			11,422,252		14,788,333		23,338,789		69,147,834

Recognized amounts of identifiable assets acquired and liabilities assumed
Cash	$	5,404,660	$	892,218		$	620,248	$	299,050	$	1,005,453	$	8,221,629
Accounts receivable		623,635		7,002,325			5,844,494		3,785,490		3,975,160		21,231,104
Other current assets		134,216		1,167,326			136,157		-		30,734		1,468,433
Property, plant and equipment		519,391		4,548,956			2,125,134		2,450,900		4,092		9,648,473
Intangible assets		2,419,600		-			387,550		125,000		10,305,000		13,237,150
Total identifiable assets acquired		9,101,502		13,610,825			9,113,583		6,660,440		15,320,439		53,806,789

Accounts payable	$	40,447	$	2,036,714		$	44,911	$	-	$	137,239	$	2,259,311
Due to seller		-		-			5,844,494		4,084,540		-		9,929,034
Other current liabilities		1,012,992		4,439,230			286,792		-		562,809		6,301,823
Total liabilities assumed		1,053,439		6,475,944			6,176,197		4,084,540		700,048		18,490,168

Goodwill/(Gain on bargain purchase)		6,009,128		(1,593,612	)		8,484,866		12,212,433		8,718,398		33,831,213

Total purchase price	$	14,057,191	$	5,541,269		$	11,422,252	$	14,788,333	$	23,338,789	$	69,147,834

Schedule of pro forma combined financial information

	2022		2021
Revenue	$	523,948,302	$	451,696,206
Net Income		38,164,837		38,743,940

ABC Transaction and Held for Sale (Tables)

12 Months Ended

Dec. 31, 2022

Transaction and Held-for-sale [Abstract]

Schedule of assets and liabilities

	December 31, 2022
	Pre ABC Adjustment			Adjustment			Post ABC Adjustment
ASSETS

Current assets:
Cash and cash equivalents	$	(190,312	)	$	190,312		$	-
Accounts receivable, net		1,219,927			(1,219,927	)		-
Prepaid expenses and other current assets		22,850			(22,850	)		-
Assets held for sale		-			4,480,344			4,480,344
Total current assets		1,052,465			3,427,879			4,480,344

Property and equipment, net		1,107,279			(1,107,279	)		-
Intangibles, net		30,697			(30,697	)		-
Goodwill		5,085,689			(5,085,689	)		-
Operating lease right-of-use assets		29,753			(29,753	)		-
Intercompany receivables		17,957,076			-			17,957,076
Other assets		96,419			(96,419	)		-
Total assets	$	25,359,378		$	(2,921,958	)	$	22,437,420

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:
Accounts payable	$	196,122		$	(196,122	)	$	-
Accrued liabilities		4,250,603			(4,250,603	)		-
Intercompany payables		59,404,839			-			59,404,839
Operating lease liability, current		33,619			(33,619	)		-
Liabilities held for sale		-			4,480,344			4,480,344
Total current liabilities		63,885,183			-			63,885,183
Total liabilities	$	63,885,183		$	-		$	63,885,183

STOCKHOLDERS’ EQUITY:
Accumulated deficit	$	(38,525,805	)	$	(2,921,958	)	$	(41,447,763	)
Total stockholders’ equity attributable to DocGo Inc. and Subsidiaries		(38,525,805	)		(2,921,958	)		(41,447,763	)
Noncontrolling interests		-			-			-
Total stockholders’ equity	$	(38,525,805	)	$	(2,921,958	)	$	(41,447,763	)
Total liabilities and stockholders’ equity	$	25,359,378		$	(2,921,958	)	$	22,437,420

Goodwill (Tables)

12 Months Ended

Dec. 31, 2022

Schedule of Changes in the Carrying Value of Goodwill [Abstract]

Schedule of changes in the carrying value of goodwill

	Carrying Value
Balance as of December 31, 2020	$	6,610,557
Goodwill acquired during the period		2,076,409
Balance as of December 31, 2021	$	8,686,966
Goodwill acquired during the period		35,299,136
Impairment during the year		(2,921,958	)
Reassignment of Goodwill to Assets held for sale		(2,163,731	)
Balance as of December 31, 2022	$	38,900,413

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1A
-URI https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 55
-Paragraph 24
-URI https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Schedule of amortization expense

Intangibles (Tables)

12 Months Ended

Dec. 31, 2022

Intangibles [Abstract]

	December 31, 2022
	Estimated Useful Life (Years)	Gross Carrying Amount		Additions			Accumulated Amortization			Net Carrying Amount
Patents	15 years	$	48,668	$	14,155		$	(10,116	)	$	52,707
Computer software	5 years		294,147		(46,319	)		(224,886	)		22,942
Operating licenses	Indefinite		8,375,514		423,490			-			8,799,004
Internally developed software	4-5 years		6,013,513		2,270,545			(6,378,911	)		1,905,147
Material contracts	Indefinite		-		62,550			-			62,550
Customer relationship	8-9 years		-		12,397,954			(594,301	)		11,803,653
Trademark	8 years		-		326,646			(3,403	)		323,243
		$	14,731,842	$	15,449,021		$	(7,211,617	)	$	22,969,246

	December 31, 2021
	Estimated Useful Life (Years)	Gross Carrying Amount		Additions		Accumulated Amortization			Net Carrying Amount
Patents	15 years	$	19,275	$	29,393	$	(6,367	)	$	42,301
Computer software	5 years		132,816		161,331		(219,388	)		74,759
Operating licenses	Indefinite		8,375,514		-		-			8,375,514
Internally developed software	4-5 years		2,146,501		3,867,012		(3,828,038	)		2,185,475
		$	10,674,106	$	4,057,736	$	(4,053,793	)	$	10,678,049

Schedule of future amortization expense definite life intangible assets

	Amortization Expense
2023	$	2,494,148
2024		1,917,338
2025		1,867,861
2026		1,453,827
2027		1,453,109
Thereafter		4,921,409
Total	$	14,107,692

Accrued Liabilities (Tables)

12 Months Ended

Dec. 31, 2022

Schedule of accrued liabilities

	December 31, 2022		December 31, 2021
Accrued bonus	$	1,500,717	$	7,260,456
Accrued lab fees		584,203		4,885,539
Accrued payroll		4,245,838		3,539,301
Medicare advance		-		975,415
FICA/Medicare liability		555,166		739,629
Accrued general expenses		11,436,462		3,497,418
Accrued subcontractors		8,101,150		9,564,833
Accrued fuel and maintenance		253,243		450,842
Accrued workers compensation and insurance liabilities		3,766,469		2,259,571
Other current liabilities		706,528		736,021
Accrued legal fees		344,417		1,143,629
Credit card payable		78,838		58,223
Total accrued liabilities	$	31,573,031	$	35,110,877

Notes Payable (Tables)

12 Months Ended

Dec. 31, 2022

Notes Payable [Abstract]

Schedule of notes payable

	December 31, 2022		December 31, 2021
Equipment and financing loans payable, between 2.5% and 8% interest and maturing between January 2022 and October 2027	$	1,901,514	$	1,903,288
Loan received pursuant to the PPP Term Note		-		-
Total notes payable		1,901,514		1,903,288
Less: current portion of notes payable	$	664,913	$	600,449
Total non-current portion of notes payable	$	1,236,601	$	1,302,839

Schedule of future minimum annual maturites of notes payable

	Notes Payable
2023	$	563,366
2024		443,416
2025		425,863
2026		345,557
Thereafter		123,312
Total maturities	$	1,901,514
Current portion of notes payable		(664,913	)
Non-current portion of notes payable	$	1,236,601

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69B
-URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69E
-URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644

Schedule of operating results for the business segments

Business Segment Information (Tables)

12 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

	Transportation Services			Mobile Health Services		Total
For the Year Ended December 31, 2022
Revenues	$	114,624,306		$	325,891,440	$	440,515,746
Income (loss) from operations		(45,676,221	)		67,507,849		21,831,628
Total assets		276,456,130			116,821,498		393,277,628
Depreciation and amortization expense		8,787,570			1,778,008		10,565,578
Stock compensation		2,013,643			6,040,928		8,054,571
Long-lived assets		32,302,611			50,825,223		83,127,834

For the Year Ended December 31, 2021
Revenues	$	84,268,817		$	234,449,763	$	318,718,580
Income (loss) from operations		(26,365,962	)		41,723,260		15,357,298
Total assets		229,206,964			80,395,688		309,602,652
Depreciation and amortization expense		5,508,679			2,002,900		7,511,579
Stock compensation		592,664			783,689		1,376,353
Long-lived assets		28,814,481			3,284,423		32,098,904

Stock Based Compensation (Tables)

12 Months Ended

Dec. 31, 2022

Stock Based Compensation [Abstract]

Schedule of fair value of the sole stock option grant

	Years Ended December 31
	2022			2021
Risk-free interest rate		0.71% - 4.31	%		0.12% - 0.67	%
Expected term (in years)		6.25			1-5
Volatility		60% - 69	%		63% - 65	%
Dividend yield		0	%		0	%

Schedule of company’s stock option activity

	Options Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years		Aggregate Intrinsic Value

Balance as of December 31, 2020		4,635,898		$	1.84		7.28	$	8,129,671
Granted/ Vested during the year		5,495,095			2.88		9.80		-
Exercised during the year		(1,235,130	)		0.50		4.32		-
Cancelled during the year		(472,891	)		2.37		7.93		-
Balance as of December 31, 2021		8,422,972		$	6.21		8.77	$	24,706,020
Granted/ Vested during the year		5,443,368			7.04		-		-
Exercised during the year		(1,699,720	)		2.03		-		-
Cancelled during the year		(595,312	)		8.28		-		-
Balance as of December 31, 2022		11,571,308			7.11		9.05	$	39,389,063
Options vested and exercisable as of December 31, 2022		2,628,288		$	6.15		8.02	$	6,982,555

Schedule of RSUs

	RSUs			Weighted- Average Grant Date Fair Value Per RSU

Balance as of December 31, 2021		50,192		$	9.97
Granted		311,637			8.17
Vested during the year		(56,242	)		5.86
Balance as of December 31, 2022		305,587			8.35
Vested and unissued as of December 31, 2022		56,242			5.86
Non-vested as of December 31, 2022		305,587			8.35

Leases (Tables)

12 Months Ended

Dec. 31, 2022

Leases [Abstract]

Schedule of comprise lease expenses

Components of total lease cost:	December 31, 2022		December 31, 2021
Operating lease expense	$	2,294,636	$	1,993,984
Short-term lease expense		1,201,622		1,012,260
Total lease cost	$	3,496,258	$	3,006,244

Components of total lease payment:	December 31, 2022		December 31, 2021
Finance lease payment	$	2,985,568	$	2,741,784
Short-term lease payment		-		-
Total lease payments	$	2,985,568	$	2,741,784

Schedule of company’s operating leases were recorded in the consolidated balance sheets

	December 31, 2022		December 31, 2021
Assets
Lease right-of-use assets	$	9,074,277	$	4,195,682
Total lease assets	$	9,074,277	$	4,195,682

Liabilities
Current liabilities:
Lease liability – current portion	$	2,325,024	$	1,461,335
Noncurrent liabilities:
Lease liability, net of current portion		7,040,982		2,980,946
Total lease liability	$	9,366,006	$	4,442,281

Schedule of weighted average remaining lease term and the weighted average discount rate

Weighted average remaining lease term (in years) – operating leases			5.57
Weighted average discount rate – operating leases			6.00	%

Weighted average remaining lease term (in years) – finance leases			4
Weighted average discount rate – finance leases			6.0	%

Schedule of future minimum lease payments under the operating leases

	Operating Leases
2023	$	2,788,584
2024		2,346,789
2025		2,345,424
2026		1,716,501
2027 and thereafter		1,440,116
Total future minimum lease payments		10,637,414
Less effects of discounting	$	(1,271,408	)
Present value of future minimum lease payments	$	9,366,006

	Finance Leases
2023	$	3,156,298
2024		2,438,224
2025		2,159,661
2026		1,377,432
2027 and thereafter		468,651
Total future minimum lease payments		9,600,266
Less effects of discounting	$	(953,463	)
Present value of future minimum lease payments	$	8,646,803

Schedule of company’s finance leases were recorded in the consolidated balance sheets

	December 31, 2022		December 31, 2021
Assets
Lease right-of-use assets	$	9,039,663	$	9,307,113
Total lease assets	$	9,039,663	$	9,307,113

Liabilities
Current liabilities:
Lease liability – current portion	$	2,732,639	$	3,271,990
Noncurrent liabilities:
Lease liability, net of current portion		5,914,164		6,867,420
Total lease liability	$	8,646,803	$	10,139,410

Other Income (loss) (Tables)

12 Months Ended

Dec. 31, 2022

Other Income and Expenses [Abstract]

Schedule of other income

	Years Ended December 31
	2022			2021

Other income (expenses):
Interest income (expense), net		762,685			(763,030	)
Gain on remeasurement of warrant liabilities		1,127,388			5,199,496
Gain (loss) on initial equity method investment		8,919			(66,818	)
Gain on remeasurement of finance leases		1,388,273			-
Gain on bargain purchase		1,593,612			-
Gain from PPP loan forgiveness		-			142,667
Loss on disposal of fixed assets		(21,173	)		(34,342	)
Goodwill impairment		(2,921,958	)		-
Other expenses		(987,482	)		(40,086	)
Total other income		950,264			4,437,887

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2022

Income Taxes [Abstract]

Schedule of company’s effective tax rate

	For the Years Ended December 31,
	2022			2021
Statutory federal income tax benefit		21.00	%		21.00	%
Permanent items		0.56	%		(2.71	)%
State taxes, net of federal tax benefit		7.77	%		5.99	%
Effects of Rates Different from Statutory		0.17	%		(0.06	)%
Rate Change		0.01	%		0.00	%
Other		(3.64	)%		(0.71	)%
Change in valuation allowance		(54.94	)%		(20.98	)%
Income tax (benefit)/provision		(29.07	)%		2.53	%

Schedule of income tax provision (benefit)

	For the Years Ended December 31,
	2022			2021
Current:
Federal	$	1,493,772		$	295,956
State and local		502,872			319,741
Foreign		-			-
	$	1,996,644		$	615,697
Deferred:
Federal	$	(7,683,475	)	$	-
State and local		(2,649,791	)		-
Foreign		375,301			-
		(9,957,965	)		-
Total income tax (benefit) expense	$	(7,961,321	)	$	615,697

Schedule of deferred tax assets and liabilities

	For the Years Ended December 31,
	2022			2021
Deferred tax assets (liabilities):
Net operating loss carryforwards	$	11,523,632			17,153,341
Allowance for doubtful accounts		893,329			874,029
Amortization		(157,839	)		(582,284	)
Prepaid expenses		(994,644	)		(411,798	)
Property and equipment		(2,798,988	)		(2,245,003	)
Research and development expense		303,446			(580,497	)
Accrued bonus		(184,724	)		1,414,357
Stock compensation		2,780,019			883,317
Other		114,080			197,218
Net deferred tax assets		11,478,311			16,702,680
Valuation allowance		(1,520,345	)		(16,702,680	)
Deferred tax assets, net of allowance	$	9,957,966		$	-

Description of Organization and Business Operations (Details) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares
Description of Organization and Business Operations (Details) [Line Items]
Price per unit (in Dollars per share) \| $ / shares	$ 0.0001
Net proceeds	$ 158.0
Cash held in trust account	43.4
Transaction costs	9.6
Underwriters’ fees	114.6
Net of transaction fees	$ 10.4
Private Placement [Member]
Description of Organization and Business Operations (Details) [Line Items]
Price per unit (in Dollars per share) \| $ / shares	$ 10

Summary of Significant Accounting Policies (Details) - USD ($)		1 Months Ended	12 Months Ended
	Nov. 01, 2021	Oct. 26, 2021	Dec. 31, 2022	Dec. 31, 2021
Summary of Significant Accounting Policies (Details) [Line Items]
Unrealized cumulative translation			$ 773,707
Percentage of revenue				26.00%
Percentage of accounts receivable				24.00%
Total cost percentage			12.00%	11.00%
Cash balances			$ 8,125,966	$ 803,000
Contingent consideration			3,000,000
Agreed to pay			2,000,000
Exceptional consideration amount			1,080,000
Goodwill impairment			$ 2,921,958
National Providers Association, LLC description	the Company acquired a 20% interest in National Providers Association, LLC (“NPA”) for $30,000. The Company uses the equity method to account for investments in which the Company has the ability to exercise significant influence over the operating and financial policies of the investee, but does not exercise control. The Company’s carrying value in the equity method investee is reflected in the caption “Equity method investment” on the Consolidated Balance Sheets. Changes in value of NPA are recorded in “Gain (loss) on equity method investment” on the Consolidated Statements of Operations. The Company’s judgment regarding its level of influence over the equity method investee includes considering key factors, such as ownership interest, representation on the board of directors, and participation in policy-making decisions. Effective December 21, 2021, three members withdrew from NPA resulting in the remaining two members obtaining the remaining ownership percentage. As of December 31, 2021 DocGo owned 50% of NPA.
Customer One [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Percentage of revenue			35.00%	23.00%
Percentage of accounts receivable			45.00%
Customer One [Member] \| Revision to Previously Reported Financial Statements [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Percentage of accounts receivable				26.00%
Business Combination [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Voting interest			10.00%
MDI [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Payments of MDI			$ 3,018,119	$ 1,746,736
Ryan Brothers Atkinson, LLC [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Contingent consideration			4,000,000
Medical Services, LLC [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Contingent consideration			2,475,540
RND Health Services Inc. [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Percentage of Interest		50.00%
Acquired amount		$ 655,876
Variable Interest Entity [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Total revenue			2,857,463
Net Loss			373,456
Total assets			610,553
Total liabilities			320,424
Total Stockholders deficit			$ 290,130

Summary of Significant Accounting Policies (Details) - Schedule of depreciation and amortization using the straight-line method over the estimated useful lives of the respective assets	12 Months Ended
	Dec. 31, 2022
Buildings [Member]
Summary of Significant Accounting Policies (Details) - Schedule of depreciation and amortization using the straight-line method over the estimated useful lives of the respective assets [Line Items]
Property, Plant and Equipment	39 years
Office equipment and furniture [Member]
Summary of Significant Accounting Policies (Details) - Schedule of depreciation and amortization using the straight-line method over the estimated useful lives of the respective assets [Line Items]
Property, Plant and Equipment	3 years
Vehicles [Member] \| Minimum [Member]
Summary of Significant Accounting Policies (Details) - Schedule of depreciation and amortization using the straight-line method over the estimated useful lives of the respective assets [Line Items]
Property, Plant and Equipment	2 years
Vehicles [Member] \| Maximum [Member]
Summary of Significant Accounting Policies (Details) - Schedule of depreciation and amortization using the straight-line method over the estimated useful lives of the respective assets [Line Items]
Property, Plant and Equipment	8 years
Medical equipment [Member]
Summary of Significant Accounting Policies (Details) - Schedule of depreciation and amortization using the straight-line method over the estimated useful lives of the respective assets [Line Items]
Property, Plant and Equipment	5 years
Leasehold improvements [Member]
Summary of Significant Accounting Policies (Details) - Schedule of depreciation and amortization using the straight-line method over the estimated useful lives of the respective assets [Line Items]
Property, Plant and Equipment	Shorter of useful life of asset or lease term

Summary of Significant Accounting Policies (Details) - Schedule of revenue is disaggregated - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Primary Geographical Markets [Member]
Primary Geographical Markets
Total revenue	$ 440,515,746	$ 318,718,580
Major Segments/Service Lines [Member]
Primary Geographical Markets
Total revenue	440,515,746	318,718,580
Transportation Services [Member] \| Major Segments/Service Lines [Member]
Primary Geographical Markets
Total revenue	114,624,306	84,268,817
Mobile Health [Member] \| Major Segments/Service Lines [Member]
Primary Geographical Markets
Total revenue	325,891,440	234,449,763
United States [Member] \| Primary Geographical Markets [Member]
Primary Geographical Markets
Total revenue	419,578,082	309,218,594
United Kingdom [Member] \| Primary Geographical Markets [Member]
Primary Geographical Markets
Total revenue	$ 20,937,664	$ 9,499,986

Summary of Significant Accounting Policies (Details) - Schedule of basic and diluted net income per share - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule Of Basic And Diluted Net Income Per Share Abstract
Net income attributable to stockholders of DocGo Inc. and Subsidiaries: (in Dollars)	$ 34,584,498	$ 23,743,758
Weighted-average shares - basic	101,228,369	80,293,959
Effect of dilutive options	1,747,462	14,569,654
Weighted-average shares - dilutive	102,975,831	94,863,613
Net income share - basic (in Dollars per share)	$ 0.34	$ 0.3
Net income share - diluted (in Dollars per share)	$ 0.34	$ 0.25
Anti-dilutive employee share-based awards excluded	9,000,750

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Property and Equipment, net (Details) - USD ($)	12 Months Ended
Property and Equipment, net (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 4,114,346	$ 2,312,437
Total disposal	$ 50,353	$ 0

Property and Equipment, net (Details) - Schedule of property and equipment, net - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property and equipment	$ 29,782,188	$ 20,881,155
Less: Accumulated depreciation	(8,524,013)	(8,147,266)
Property and equipment, net	21,258,175	12,733,889
Office equipment and furniture [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	2,686,065	1,977,808
Buildings [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	527,283	527,284
Land [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	37,800	37,800
Transportation equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	20,773,862	13,772,251
Medical equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	5,177,520	3,949,566
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	$ 579,658	$ 616,446

Acquisitions (Details) - USD ($)				3 Months Ended	12 Months Ended
Acquisitions (Details) - USD ($)	Oct. 12, 2022	Aug. 09, 2022	Jul. 13, 2022	Dec. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 09, 2022	Jul. 06, 2022
Acquisitions (Details) [Line Items]
Cash consideration				$ 8,221,629	$ 8,221,629
Gain on bargain purchase	$ 1,593,612				(1,593,612)
Contingent consideration				10,555,540	10,555,540
Series of Individually Immaterial Asset Acquisitions [Member]
Acquisitions (Details) [Line Items]
Acquisition amount	7,134,881
Government Medical Services, LLC [Member]
Acquisitions (Details) [Line Items]
Outstanding shares of common stock percentage								100.00%
Cash consideration								$ 20,338,789,000,000
Additional amount								$ 3,000,000,000,000
General and administrative expenses					1,001,883,000,000
Exceptional Medical Transportation, LLC [Member]
Acquisitions (Details) [Line Items]
Business combination common stock, description			the Company acquired 100% of the outstanding shares of common stock of Exceptional Medical Transportation, LLC (“Exceptional”) in exchange for $13,708,333 consisting of $7,708,333 in cash at closing and $6,000,000 payable over a 24 month period. Holdings also agreed to pay an estimated $1,080,000 Contingent consideration upon Exceptional meeting certain performance conditions in 2023. Exceptional is in the business of providing medical transportation services. Acquisition costs are included in general and administrative expenses totaled $56,571 for the twelve months ended December 31, 2022.
Ryan Brothers Fort Atkinson, LLC [Member]
Acquisitions (Details) [Line Items]
Business combination common stock, description		the Company acquired 100% of the outstanding shares of common stock of Ryan Brothers Fort Atkinson, LLC (“RB”) in exchange for $11,422,252 consisting of $7,422,252 in cash at closing and $4,000,000 of estimated Contingent consideration to be paid out over 24 months based on performance of certain obligations. RB is in the business of providing medical transportation services. Acquisition costs are included in general and administrative expenses totaled $230,175 for the twelve months ended December 31, 2022.
Community Ambulance Services LTD [Member]
Acquisitions (Details) [Line Items]
General and administrative expenses				171,779,000	171,779,000
Cash	$ 5,541,269,000,000
Location Medical Services, LLC [Member]
Acquisitions (Details) [Line Items]
Outstanding shares of common stock percentage							100.00%
Cash consideration							$ 302,450,000,000
Additional amount							11,279,201,000,000
General and administrative expenses				$ 4,200,000	$ 4,200,000
Contingent consideration							$ 2,475,540,000,000

Acquisitions (Details) - Schedule of preliminary allocation of the assets acquired and liabilities assumed	12 Months Ended
	Dec. 31, 2022 USD ($)
Consideration:
Cash consideration	$ 39,979,760
Deferred consideration	17,279,201
Amounts held under an escrow account	1,333,333
Contingent consideration	10,555,540
Total consideration	69,147,834
Recognized amounts of identifiable assets acquired and liabilities assumed
Cash	8,221,629
Accounts receivable	21,231,104
Other current assets	1,468,433
Property, plant and equipment	9,648,473
Intangible assets	13,237,150
Total identifiable assets acquired	53,806,789
Accounts payable	2,259,311
Due to seller	9,929,034
Other current liabilities	6,301,823
Total liabilities assumed	18,490,168
Goodwill/(Gain on bargain purchase)	33,831,213
Total purchase price	69,147,834
Location Medical Services [Member]
Consideration:
Cash consideration	302,450
Deferred consideration	11,279,201
Amounts held under an escrow account
Contingent consideration	2,475,540
Total consideration	14,057,191
Recognized amounts of identifiable assets acquired and liabilities assumed
Cash	5,404,660
Accounts receivable	623,635
Other current assets	134,216
Property, plant and equipment	519,391
Intangible assets	2,419,600
Total identifiable assets acquired	9,101,502
Accounts payable	40,447
Due to seller
Other current liabilities	1,012,992
Total liabilities assumed	1,053,439
Goodwill/(Gain on bargain purchase)	6,009,128
Total purchase price	14,057,191
Community Ambulance Service [Member]
Consideration:
Cash consideration	5,541,269
Deferred consideration
Amounts held under an escrow account
Contingent consideration
Total consideration	5,541,269
Recognized amounts of identifiable assets acquired and liabilities assumed
Cash	892,218
Accounts receivable	7,002,325
Other current assets	1,167,326
Property, plant and equipment	4,548,956
Intangible assets
Total identifiable assets acquired	13,610,825
Accounts payable	2,036,714
Due to seller
Other current liabilities	4,439,230
Total liabilities assumed	6,475,944
Goodwill/(Gain on bargain purchase)	(1,593,612)
Total purchase price	5,541,269
Ryan Brothers [Member]
Consideration:
Cash consideration	7,422,252
Deferred consideration
Amounts held under an escrow account
Contingent consideration	4,000,000
Total consideration	11,422,252
Recognized amounts of identifiable assets acquired and liabilities assumed
Cash	620,248
Accounts receivable	5,844,494
Other current assets	136,157
Property, plant and equipment	2,125,134
Intangible assets	387,550
Total identifiable assets acquired	9,113,583
Accounts payable	44,911
Due to seller	5,844,494
Other current liabilities	286,792
Total liabilities assumed	6,176,197
Goodwill/(Gain on bargain purchase)	8,484,866
Total purchase price	11,422,252
Exceptional Medical Transport [Member]
Consideration:
Cash consideration	6,375,000
Deferred consideration	6,000,000
Amounts held under an escrow account	1,333,333
Contingent consideration	1,080,000
Total consideration	14,788,333
Recognized amounts of identifiable assets acquired and liabilities assumed
Cash	299,050
Accounts receivable	3,785,490
Other current assets
Property, plant and equipment	2,450,900
Intangible assets	125,000
Total identifiable assets acquired	6,660,440
Accounts payable
Due to seller	4,084,540
Other current liabilities
Total liabilities assumed	4,084,540
Goodwill/(Gain on bargain purchase)	12,212,433
Total purchase price	14,788,333
Government Medical Services [Member]
Consideration:
Cash consideration	20,338,789
Deferred consideration
Amounts held under an escrow account
Contingent consideration	3,000,000
Total consideration	23,338,789
Recognized amounts of identifiable assets acquired and liabilities assumed
Cash	1,005,453
Accounts receivable	3,975,160
Other current assets	30,734
Property, plant and equipment	4,092
Intangible assets	10,305,000
Total identifiable assets acquired	15,320,439
Accounts payable	137,239
Due to seller
Other current liabilities	562,809
Total liabilities assumed	700,048
Goodwill/(Gain on bargain purchase)	8,718,398
Total purchase price	$ 23,338,789

Acquisitions (Details) - Schedule of pro forma combined financial information - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule of Pro Forma Combined Financial Information [Abstract]
Revenue	$ 523,948,302	$ 451,696,206
Net Income	$ 38,164,837	$ 38,743,940

The aggregate cost of goods produced and sold and services rendered during the reporting period.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2)
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

ABC Transaction and Held for Sale (Details) - Schedule of assets and liabilities	Dec. 31, 2022 USD ($)
Pre ABC Adjustment [Member]
Current assets:
Cash and cash equivalents	$ (190,312)
Accounts receivable, net	1,219,927
Prepaid expenses and other current assets	22,850
Assets held for sale
Total current assets	1,052,465
Property and equipment, net	1,107,279
Intangibles, net	30,697
Goodwill	5,085,689
Operating lease right-of-use assets	29,753
Intercompany receivables	17,957,076
Other assets	96,419
Total assets	25,359,378
Current liabilities:
Accounts payable	196,122
Accrued liabilities	4,250,603
Intercompany payables	59,404,839
Operating lease liability, current	33,619
Liabilities held for sale
Total current liabilities	63,885,183
Total liabilities	63,885,183
STOCKHOLDERS’ EQUITY:
Accumulated deficit	(38,525,805)
Total stockholders’ equity attributable to DocGo Inc. and Subsidiaries	(38,525,805)
Noncontrolling interests
Total stockholders’ equity	(38,525,805)
Total liabilities and stockholders’ equity	25,359,378
Adjustment [Member]
Current assets:
Cash and cash equivalents	190,312
Accounts receivable, net	(1,219,927)
Prepaid expenses and other current assets	(22,850)
Assets held for sale	4,480,344
Total current assets	3,427,879
Property and equipment, net	(1,107,279)
Intangibles, net	(30,697)
Goodwill	(5,085,689)
Operating lease right-of-use assets	(29,753)
Other assets	(96,419)
Total assets	(2,921,958)
Current liabilities:
Accounts payable	(196,122)
Accrued liabilities	(4,250,603)
Operating lease liability, current	(33,619)
Liabilities held for sale	4,480,344
Total current liabilities
Total liabilities
STOCKHOLDERS’ EQUITY:
Accumulated deficit	(2,921,958)
Total stockholders’ equity attributable to DocGo Inc. and Subsidiaries	(2,921,958)
Noncontrolling interests
Total stockholders’ equity	(2,921,958)
Total liabilities and stockholders’ equity	(2,921,958)
Post ABC Adjustment [Member]
Current assets:
Cash and cash equivalents
Accounts receivable, net
Prepaid expenses and other current assets
Assets held for sale	4,480,344
Total current assets	4,480,344
Property and equipment, net
Intangibles, net
Goodwill
Operating lease right-of-use assets
Intercompany receivables	17,957,076
Total assets	22,437,420
Current liabilities:
Accounts payable
Intercompany payables	59,404,839
Operating lease liability, current
Liabilities held for sale	4,480,344
Total current liabilities	63,885,183
Total liabilities	63,885,183
STOCKHOLDERS’ EQUITY:
Accumulated deficit	(41,447,763)
Total stockholders’ equity attributable to DocGo Inc. and Subsidiaries	(41,447,763)
Noncontrolling interests
Total stockholders’ equity	(41,447,763)
Total liabilities and stockholders’ equity	$ 22,437,420

Goodwill (Details) - USD ($)	12 Months Ended
Goodwill (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Legal Proceedings [Abstract]
Recognized a non-cash charge	$ 2,921,958
Total goodwill acquired	35,299,136
Carrying value of goodwill	$ 38,900,413	$ 8,686,966

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References + Details

Goodwill (Details) - Schedule of changes in the carrying value of goodwill - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Schedule of Changes in the Carrying Value of Goodwill [Abstract]
Balance	$ 8,686,966	$ 6,610,557
Goodwill acquired during the period		2,076,409
Balance	38,900,413	$ 8,686,966
Goodwill acquired during the period	35,299,136
Impairment during the year	(2,921,958)
Reassignment of Goodwill to Assets held for sale	$ (2,163,731)

Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.

+ References + Details

Intangibles (Details) - USD ($)	12 Months Ended
Intangibles (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Intangibles [Abstract]
Amortization expense	$ 3,214,814	$ 1,845,193

Intangibles (Details) - Schedule of amortization expense - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Additions		$ 4,057,736
Net Carrying Amount		10,678,049
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount		10,674,106
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Accumulated Amortization		$ (4,053,793)
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (Years)	15	15
Additions	$ 14,155	$ 29,393
Net Carrying Amount	52,707	42,301
Patents [Member] \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	48,668	19,275
Patents [Member] \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Accumulated Amortization	$ (10,116)	$ (6,367)
Computer software [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (Years)	5	5
Additions	$ (46,319)	$ 161,331
Net Carrying Amount	22,942	74,759
Computer software [Member] \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	294,147	132,816
Computer software [Member] \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Accumulated Amortization	$ (224,886)	$ (219,388)
Operating licenses [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (Years)	Indefinite	Indefinite
Additions	$ 423,490
Net Carrying Amount	8,799,004	$ 8,375,514
Operating licenses [Member] \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	8,375,514	8,375,514
Operating licenses [Member] \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Accumulated Amortization
Internally developed software [Member]
Finite-Lived Intangible Assets [Line Items]
Additions	2,270,545	3,867,012
Net Carrying Amount	$ 1,905,147	$ 2,185,475
Internally developed software [Member] \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (Years)	4	4
Gross Carrying Amount	$ 6,013,513	$ 2,146,501
Internally developed software [Member] \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (Years)	5	5
Accumulated Amortization	$ (6,378,911)	$ (3,828,038)
Material Contracts [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (Years)	Indefinite
Additions	$ 62,550
Net Carrying Amount	62,550
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Additions	12,397,954
Net Carrying Amount	$ 11,803,653
Customer Relationships [Member] \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (Years)	8
Customer Relationships [Member] \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (Years)	9
Accumulated Amortization	$ (594,301)
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life (Years)	8
Additions	$ 326,646
Net Carrying Amount	323,243
Trademarks [Member] \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Accumulated Amortization	$ (3,403)

Intangibles (Details) - Schedule of future amortization expense definite life intangible assets	Dec. 31, 2022 USD ($)
Schedule of amortization expense for the next five years in aggregate [Abstract]
2023	$ 2,494,148
2024	1,917,338
2025	1,867,861
2026	1,453,827
2027	1,453,109
Thereafter	4,921,409
Total	$ 14,107,692

Accrued Liabilities (Details) - Schedule of accrued liabilities - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Schedule of Accrued Liabilities [Abstract]
Accrued bonus	$ 1,500,717	$ 7,260,456
Accrued lab fees	584,203	4,885,539
Accrued payroll	4,245,838	3,539,301
Medicare advance		975,415
FICA/Medicare liability	555,166	739,629
Accrued general expenses	11,436,462	3,497,418
Accrued subcontractors	8,101,150	9,564,833
Accrued fuel and maintenance	253,243	450,842
Accrued workers compensation and insurance liabilities	3,766,469	2,259,571
Other current liabilities	706,528	736,021
Accrued legal fees	344,417	1,143,629
Credit card payable	78,838	58,223
Total accrued liabilities	$ 31,573,031	$ 35,110,877

Line of Credit (Details) - USD ($)		1 Months Ended
Line of Credit (Details) - USD ($)	Nov. 01, 2022	Jan. 26, 2022	Dec. 17, 2021	Dec. 31, 2022
Line of Credit (Details) [Line Items]
Revolving advance amount			$ 12,000,000
Revolving advances description			Each Revolving Advance shall bear interest at a per annum rate equal to the Wall Street Journal Prime Rate (7.75% as of March 10, 2023), as the same may change from time to time, plus one percent (1.00%), but in no event less than five percent (5.00%) per annum, calculated on the basis of a 360-day year for the actual number of days in the applicable period.
Unused fee				0.50%
Revolving commitment amount				$ 12,000,000,000,000
Fund operations		$ 1,000,000
Maximum revolving advance amount	$ 90,000,000
Revolving facility amount increase	$ 50,000,000
SOFR loan	1.25%
Base rate loan	0.25%
Outstanding balance amount				$ 0
DocGo Inc [Member]
Line of Credit (Details) [Line Items]
Loan secured by assets				100.00%

Notes Payable (Details) - USD ($)	12 Months Ended
Notes Payable (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Notes Payable (Details) [Line Items]
Aggregate installment amount	$ 76,546
Interest expense	$ 117,664	$ 61,324
Minimum [Member]
Notes Payable (Details) [Line Items]
Interest range percentage	2.50%	2.50%
Maximum [Member]
Notes Payable (Details) [Line Items]
Interest range percentage	8.00%	8.00%

Notes Payable (Details) - Schedule of notes payable - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Schedule of Notes Payable [Abstract]
Equipment and financing loans payable, between 2.5% and 8% interest and maturing between January 2022 and May 2051	$ 1,901,514	$ 1,903,288
Loan received pursuant to the PPP Term Note
Total notes payable	1,901,514	1,903,288
Less: current portion of notes payable	664,913	600,449
Total non-current portion of notes payable	$ 1,236,601	$ 1,302,839

Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References + Details

Notes Payable (Details) - Schedule of notes payable (Parentheticals)	Dec. 31, 2022	Dec. 31, 2021
Minimum [Member]
Schedule of Notes Payable [Abstract]
Equipment and financing loans payable	2.50%	2.50%
Maximum [Member]
Schedule of Notes Payable [Abstract]
Equipment and financing loans payable	8.00%	8.00%

Notes Payable (Details) - Schedule of future minimum annual maturites of notes payable	Dec. 31, 2022 USD ($)
Schedule of Future Minimum Annual Maturites of Notes Payable [Abstract]
2022	$ 563,366
2024	443,416
2025	425,863
2026	345,557
Thereafter	123,312
Total maturities	1,901,514
Current portion of notes payable	(664,913)
Non-current portion of notes payable	$ 1,236,601

Derivative Warrant Liabilities (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Derivative Warrant Liabilities (Details) [Line Items]
Gain on remeasurement of warrant liabilities		$ 5.2
Remeasurement of warrant liabilities	$ 1.1
Warrants exercise	1,406,371
Redemption of warrant	68,514
Warrant per share	$ 0.1
Public Warrants [Member]
Derivative Warrant Liabilities (Details) [Line Items]
Number of warrants		3,833,333
Fair value		$ 8.1
Private Placement Warrants [Member]
Derivative Warrant Liabilities (Details) [Line Items]
Number of warrants		2,533,333
Fair value		$ 5.4

Business Segment Information (Details)	12 Months Ended
Business Segment Information (Details)	Dec. 31, 2022
Segment Reporting [Abstract]
Number of operating segments	2

Business Segment Information (Details) - Schedule of operating results for the business segments - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Segment Reporting Information [Line Items]
Revenues	$ 440,515,746	$ 318,718,580
Income (loss) from operations	21,831,628	15,357,298
Total assets	393,277,628	309,602,652
Depreciation and amortization expense	10,565,578	7,511,579
Stock compensation	8,054,571	1,376,353
Long-lived assets	83,127,834	32,098,904
Transportation Services [Member]
Segment Reporting Information [Line Items]
Revenues	114,624,306	84,268,817
Income (loss) from operations	(45,676,221)	(26,365,962)
Total assets	276,456,130	229,206,964
Depreciation and amortization expense	8,787,570	5,508,679
Stock compensation	2,013,643	592,664
Long-lived assets	32,302,611	28,814,481
Mobile Health Services [Member]
Segment Reporting Information [Line Items]
Revenues	325,891,440	234,449,763
Income (loss) from operations	67,507,849	41,723,260
Total assets	116,821,498	80,395,688
Depreciation and amortization expense	1,778,008	2,002,900
Stock compensation	6,040,928	783,689
Long-lived assets	$ 50,825,223	$ 3,284,423

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227